EchoStar CORP: Form 10-K for the period ended Dec 31, 2022
Filed with the SEC on Feb 23, 2023 and accepted by EDGAR at Feb 22, 2023, 17:59 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2022-01-01 to 2022-12-31 | $2.00bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Research and development | 12 months2022-01-01 to 2022-12-31 | $32.8m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2022-01-01 to 2022-12-31 | $455.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2022-01-01 to 2022-12-31 | $189.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2022-01-01 to 2022-12-31 | $57.2m | us-gaap:InterestExpense |
| Income tax | 12 months2022-01-01 to 2022-12-31 | $66.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2022-01-01 to 2022-12-31 | $166.5m | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2022-01-01 to 2022-12-31 | $2.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2022-01-01 to 2022-12-31 | $2.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2022-01-01 to 2022-12-31 | 84,123,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2022-01-01 to 2022-12-31 | $529.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2022-01-01 to 2022-12-31 | $325.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2022-01-01 to 2022-12-31 | $89.3m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-12-31 | $704.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-12-31 | $2.13bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-12-31 | $6.20bn | us-gaap:Assets |
| Current liabilities | At period end2022-12-31 | $422.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-12-31 | $2.60bn | us-gaap:Liabilities |
| Long-term debt | At period end2022-12-31 | $1.50bn | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2022-12-31 | $3.50bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001415404-23-000005. Last ingested by Listed: Nov 3, 2026, 08:39 ET. Listed shows no prices and gives no investment advice.